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Introduction
Recent reviews have described the potential adverse ef
fects of obesity on quality of life (1,2). Impairments have
been reported in physical functioning, including general
health (3– 6) and bodily pain (7), as well as in psychosocial
status (8). In the latter domain, as many as 20% to 30% of
individuals who seek weight reduction have been found to
suffer from binge eating (9,10) or depression (11,12).
Over the past 20 years, numerous instruments have been
developed to assess quality of life (1,2,13,14). This article
briefly reviews the meaning of this term and then examines
measures that are likely to be the most useful with obese
persons. Four sets of instruments are examined. The first
consists of generic, broad-spectrum measures that assess
multiple domains including physical, social, and vocational
functioning. The second set consists of condition-specific
measures that assess symptoms or experiences that are most
likely to occur in patients with obesity (e.g., stigmatization,
body image concerns, food preoccupation). The third and
fourth sets of instruments assess depression and binge eat
ing, respectively. We believe that these two complications
should be evaluated, in addition to the more general con
struct of quality of life.

Health-Related Quality of Life
Quality of life has become a buzz word in medicine,
psychology, and society at large. The term is used to de
scribe events that range from satisfaction with one’s work or
leisure activities to the physical and economic burden im
posed by specific illnesses (15). Katschnig (16) has aptly
conveyed the breadth of this construct, defining quality of
life as a “loosely related body of work on psychological
well-being, social and emotional functioning, health status,
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functional performance, life satisfaction, social support, and
standard of living, whereby normative, objective, and sub
jective indicators of physical, social and emotional func
tioning are all used.” The present review focuses on healthrelated quality of life (HRQOL). This domain typically
assesses patients’ limitations in physical, emotional, social,
or vocational functioning, using either general constructs or
those developed to capture dysfunction associated with spe
cific diseases.
The HRQOL measures reviewed here were selected on
the basis of their (1) relevance to obesity; (2) psychometric
properties (i.e., high reliability and validity); (3) acceptance
by researchers (i.e., widespread use); and (4) ease of ad
ministration (i.e., low cost and patient/administrator bur
dens). Although no instrument is ideal, there are several
good options for use with obese individuals.
Generic Measures of HRQOL
Generic measures assess multiple domains of functioning
including mobility, self-care, and physical, emotional, and
social functioning. They may be used with a wide range of
patient populations (17). These instruments allow investi
gators to compare the degree of impairment or suffering
associated with different illnesses, as well as relative im
provements in functioning in response to treatment. They
may, however, lack precision in measuring outcomes that
are specific to the concerns of obese individuals (e.g., poor
body image, food preoccupation).
Medical Outcomes Study: Short Form-36. The most com
monly used generic instrument is the Medical Outcomes
Study questionnaire. It was originally developed to measure
health outcomes as part of a 2-year observational study of
more than 22,000 adults (18). The questionnaire was mod
ified in 1989 (19) and again in 1992 to the current 36-item
Short-Form General Health Survey (SF-36) (20).
The SF-36 assesses eight health domains: 1) limitations
in physical activities because of health problems; 2) reduc
tions in usual role activities attributable to physical or
emotional problems; 3) limitations in usual role activities
because of physical health problems; 4) bodily pain; 5)
general mental health (i.e., psychological distress and well

Table 1. Reliability and validity of SF-36 scales
Scale
Physical functioning
Role limitation
(physical)
Pain
Social function
Role limitation
(emotional)
General health
Vitality
Mental health

Internal
Test–retest
consistency reliability Validity
0.92

0.81

�0.63

0.83
0.81
0.85

0.69
0.78
0.60

�0.46
�0.59
�0.67

0.83
0.79
0.87
0.90

0.63
0.80
0.80
0.75

0.38
0.45
0.45
0.60

Internal consistency and reliability coefficients are based on gen
eral practice patients in the United Kingdom (24). Validity coef
ficients are in relation to a variety of quality of life measures (24).
Negative validity coefficients reflect scales that are scored in
opposite directions.
SF-36, short form-36.

being); 6) limitations in role activities because of emotional
problems; 7) vitality (i.e., energy and fatigue); and 8) gen
eral health perceptions (20). Six of the eight domains load
on factors that assess either physical health (physical func
tioning, physical role, and bodily pain) or behavioral health
(mental health, emotional role, and social functioning) (21).
Of the 36 items, 39% evaluate activity levels (22). Time for
completing the questionnaire is 5 to 10 minutes.
The SF-36 has well-established internal consistency, test–
retest reliability, and validity (20,23) (see Table 1), as demon
strated in a variety of patient populations throughout the world
(24). In obese populations, increasing impairment (particularly
on scales assessing physical dimensions; Table 2) has been
reported with increasing weight (4,25–32). Improved function
ing has been observed with weight loss (principally on scales
assessing physical health) (28,33). Most studies of weight loss
have been with surgical interventions (1,33,34), although
investigations of lifestyle modification (7,35) and pharma
cotherapy (36) have recently appeared.
The Nottingham Health Profile. The Nottingham Health
Profile (NHP) was developed in England in 1975, based on
interviews with 768 patients with a variety of chronic med
ical conditions. The current version was published in 1981
(37). The instrument contains 45 subjective statements di
vided into two parts. Part I includes 38 items that assess
distress in the following six domains: 1) energy; 2) physical
mobility; 3) emotional reaction; 4) pain; 5) sleep; and 6)
social isolation. Part II assesses the degree to which health
problems affect the following seven domains: 1) occupa-

tion; 2) ability to perform jobs around the house; 3) social
life; 4) home relationships; 5) sex life; 6) hobbies; and 7)
holidays (29). The instrument takes 10 to 15 minutes to
complete.
The NHP has adequate internal consistency (�0.58) and
strong validity (37–39). It has been translated into many
languages (38,40 – 43) and used in diverse medical and
patient populations (38,39). The NHP has not been widely
used with obese individuals, although two studies found
improvements on the scale after surgically induced weight
loss (44,45). The instrument seems to capture treatmentrelated changes with other medical conditions (38,39).
The Sickness Impact Profile. The Sickness Impact Profile
(SIP) is a 136-item general health status questionnaire that
is widely used in the United States and Europe (46 – 48). It
emphasizes observable behavior (e.g., “I sit during much of
the day”) and does not contain subjective evaluations of
well-being. The SIP measures two primary dimensions:
physical functioning (body care and movement, walking,
and mobility) and psychosocial functioning (emotional be
havior, social interaction, alertness behavior, and commu
nication). It requires �30 minutes to complete. Therefore, it
is more burdensome to patients than the previously de
scribed instruments. Although a shorter 68-item version of
the SIP has been constructed (49,50), it is not yet widely
used and awaits further validation.
The SIP has strong internal consistency and test-retest
reliability (r � 0.81 to 0.97), but only modest criterion
validity with other clinical measures of disease (r � 0.38 to
0.48) (46). It has been translated into several languages
and used in a variety of medical populations (51). As with
the NHP, few studies have used the SIP with obese indi
viduals (52,53).
Obesity-Specific Measures of HRQOL
In contrast to generic measures, condition-specific instru
ments are designed to capture symptoms or experiences
associated with a specific disorder. There are, for example,
quality of life instruments designed specifically for patients
with diabetes (54), arthritis (55), and asthma (56), to name
but a few. Several instruments have been developed for
obesity (3– 6,57–59). An obesity-specific measure has the
potential advantage of capturing experiences that are fre
quently reported by obese individuals, such as feeling so
cially uncomfortable when swimming in public, shopping
for clothes, or applying for a job. Such experiences are not
assessed by generic measures of HRQOL or by mood in
ventories. In addition, condition-specific measures tend to
be more sensitive to change than are generic measures
(60,61). The main disadvantage of obesity-specific instru
ments is their limited empirical validation, which is due
primarily to their having been only recently developed, and
thus, not widely used.

Table 2. SF-36 scales
Concepts
Physical functioning

No. of
items

Range of functioning

10

Limited a lot in performing all physical
activities including bathing or
dressing due to health

Role-physical

4

Bodily pain
General health

2
5

Vitality

4

Problems with work or other daily
activities as a result of physical
health
Very severe and extremely limiting pain
Evaluates personal health as poor and
believes it is likely to get worse
Feels tired and worn out all of the time

Social functioning

2

Role-emotional

3

Mental health

5

Reported health
transition

1

Extreme and frequent interference with
normal social activities due to
physical or emotional problems
Problems with work or other daily
activities as a result of emotional
problems
Feelings of nervousness and depression
all of the time
Believes general health is much worse
now than one year ago

Performs all types of physical
activities including the most
vigorous without limitation due to
health
No problems with work or other
daily activities as a result of
physical health
No pain or limitation due to pain
Evaluates personal health as excellent
Feels full of pep and energy all of
the time
Performs normal social activities with
out interference due to physical or
emotional problems
No problems with work or other
daily activities as a result of
emotional problems
Feels peaceful, happy, and calm all
of the time
Believes general health is much
better now than one year ago

Adapted from Ware and Sherbourne (20).
SF-36, short form-36.

Impact of Weight on Quality of Life Questionnaire. The
Impact of Weight on Quality of Life Questionnaire
(IWQOL) is a 74-item self-report measure that requires
�15 minutes to complete (5). The instrument asks respon
dents to describe the effects that their weight has on their
functioning in eight areas including 1) health; 2) social/
interpersonal status; 3) work; 4) mobility; 5) self-esteem; 6)
sex; 7) activities of daily living; and 8) eating. A new
31-item version of the questionnaire assesses function in
five areas (i.e., physical function, self-esteem, sexual life,
public distress, and work) (62). Preliminary data indicate
that both the long (5,63) and short (62,64,65) versions of the
questionnaire have good test–retest reliability and internal
consistency. Both questionnaires also revealed significant
improvements in all domains of functioning with weight
reduction (62– 64).
The IWQOL includes scales that capture experiences that
are specific to obese individuals. Examples include: “Because of my weight, I experience discrimination by others,”

and “Because of my weight, I am self-conscious.” Potential
drawbacks of the IWQOL include uncertainty concerning
the clinical significance of the complaints reported. Data,
for example, are needed to indicate the level at which
problems with self-esteem or eating behavior meet criteria
for established behavioral disorders, as described in the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth edition (66). Such data would help practitioners
distinguish experiences that may detract from optimal hap
piness or functioning from those that truly impair social,
vocational, or mental status. Data are also needed to deter
mine what constitutes a clinically significant change in
function in each domain, and the relative contribution of
each domain to overall functioning. Finally, the IWQOL
asks participants to report the occurrence of negative or
adverse experiences and to infer the cause of these experi
ences, as suggested by the wording, “Because of my weight,
I . . .” It would be useful to compare responses to the instrument with and without the inclusion of this inference.

Obesity-Related Problem Scale. The Obesity-Related
Problem Scale (OP) is a brief condition-specific measure
that was designed for the Swedish Obese Subjects (SOS)
study. This investigation is evaluating the long-term effects
of weight loss (achieved by bariatric surgery or conven
tional dieting) on changes in physical and psychosocial
health (58). As described by its authors, the OP measures
the effects of obesity on psychosocial functioning in every
day life (58). The 8-item scale asks respondents how both
ered they are by their obesity in relation to going to a party,
going to restaurants or community activities, taking a vaca
tion, trying on and buying clothes, swimming in public
places, and having intimate relations.
The OP is psychometrically valid (67) and seems to be
responsive to weight reduction in both surgically and con
ventionally treated patients (58,67). The SOS study found a
dose-response relationship between weight loss and changes
in OP scale scores (i.e., the more weight loss, the greater
the reduction of obesity-related psychosocial problems)
(13,67). The scale, however, has not been widely used
outside of the SOS study, and convergent and discriminant
validity have yet to be determined. As with the IWQOL
described above, it also is difficult with the OP to determine
the clinical significance of the complaints reported or of
the improvements in functioning that may occur with
weight loss.
Summary Evaluation and Recommendation
In summary, the SF-36, NHP, and SIP have acceptable
psychometric properties and have been standardized on
diverse populations. They all measure physical and social
domains, and the SF-36 and NHP also assess subjective
factors. The SF-36 is recommended for a short yet compre
hensive measure of HRQOL. It is the least burdensome for
respondents and is easy to administer. It has extensive
psychometric validation and has been normed by age and
gender for the United States and other populations. Its scales
are responsive to treatment of numerous medical conditions,
including obesity. In addition, the SF-36 will allow re
searchers to compare the burdens imposed by obesity with
those associated with other disorders. For investigators who
desire an obesity-specific measure of quality of life, we
recommend the IWQOL, with the qualifications noted. The
OP may be useful but needs further investigation in a
broader sample of overweight and obese individuals (rather
than simply those eligible for bariatric surgery).

Mood and Binge Eating
The SF-36 contains a measure of general mental health. If
patients score within normal limits on this scale, further
assessment may not be necessary. However, given the in
creased prevalence of dysthymia and depression in obese
individuals who seek weight reduction (12,68 –70), partic-

ularly among the severely obese (69), we believe it is
appropriate to assess mood more fully. Similarly, patients
should be evaluated for the presence of an eating disorder,
a domain that it is not covered by the SF-36 or any other
general measures of quality of life.
Mood
Early population studies generally found few significant
differences in psychopathology between obese and nonobese individuals (12). However, a recent well-designed
investigation showed that excess weight in women was
associated with an increased risk of major depression, sui
cide attempts, and suicidal ideation (71). (Surprisingly, in
men the inverse was found; excess weight was associated
with a decreased risk of depression and suicidality.) In
creased levels of depression and other psychopathology are
common in obese men and women who seek weight-loss
treatment (11,72).
The Beck Depression Inventory-II (BDI-II) (73) is a
21-item questionnaire that measures specific symptoms of
depression. It is easy to complete (in �5 minutes), score,
and interpret, and its internal consistency, test–retest reli
ability, and validity are well established (73). Other mea
sures of depression are available, including the Hamilton
Rating Scale for Depression (74) and the Center for Epide
miological Studies measure of Depression (75). However,
we recommend the BDI-II because of its widespread use
and minimal inclusion of items biased by obesity. The
BDI-II has been used extensively with obese individuals
and is responsive to both weight reduction (76,77) and
cognitive interventions (78).
Eating Disorders
Approximately 20% to 30% of obese individuals who
seek weight loss report problems with binge eating
(9,10,79), usually in association with a depressed mood or
related complications (9,80 – 84). Binge-eating disorder
(BED) is characterized by the consumption of large
amounts of food in a discrete period of time and by the
patient’s report of loss of control during the episode. The
overeating is not followed by compensatory behaviors (such
as vomiting or laxative abuse), thus distinguishing BED
from bulimia nervosa. Marked distress must occur in at least
three areas, including eating very rapidly, eating until un
comfortably full, eating when not hungry, eating alone, or
feeling guilty after a binge (66). Binge eating is a reliable
marker of symptoms of depression. By contrast, multiple
studies have shown that mood is essentially normal in obese
individuals who do not suffer from binge eating (68).
At least three self-administered questionnaires are cur
rently used to assess BED. The Questionnaire on Eating and
Weight Patterns-Revised (QEWP-R) (9,10) is a 28-item
instrument that provides decision rules for diagnosing BED,
bulimia nervosa, and related eating disorders. It has been

found to have adequate validity and reliability (9). The
principal drawback of the QEWP-R is that diagnosis should
be confirmed by a brief interview. Alternatively, the Binge
Eating Scale (BES) (85) is an easily administered 16-item
questionnaire that assesses symptoms of binge eating. The
scale has adequate internal consistency and validity (85).
The BES, however, was developed before the introduction
of criteria for BED, and the scale does not include several
items needed to diagnose this condition. The BES and
QEWP-R are only moderately correlated (� � 0.58) (86).
A third option is the Eating Disorder Examination Ques
tionnaire (EDE-Q) (87), a self-report version of the 30- to
60-minute structured interview developed by Cooper and
Fairburn (88) to assess bulimia nervosa and related disor
ders, including BED. The validity of the EDE-Q for diag
nosing BED in obese individuals is still being determined
(89 –91). If favorable results are obtained, this may be the
preferred instrument because, in addition to yielding diag
noses, it includes subscales that measure dietary restraint,
shape concerns, and related variables. However, until addi
tional data are available, we recommend the use of the
QEWP-R in conjunction with a 5- to 10-minute interview.
The interview allows the practitioner to confirm that pa
tients who report binge eating, in fact, routinely eat an
objectively large amount of food and experience loss of
control. The QEWP-R and self-report questionnaires, in
general, may overestimate the frequency of binge episodes
(92). The interview serves, in part, to address this limitation.

Summary
To assess the impact of obesity on general quality of life,
we recommend the SF-36 because of its brevity, ease of
administration and coverage of both physical and psycho
social domains. In addition, it provides norms for numerous
age groups and patient populations. We also recommend the
use of the BDI-II and QEWP-R to assess depression and
binge eating, respectively. These latter complications are
frequently observed in obese patients who seek treatment.
Current findings indicate that a substantial portion of
obese individuals in the general population experience un
desired physical or social consequences of their weight that
diminish their quality of life in one or more areas (68,70).
These complications typically do not require professional
attention, but nevertheless, are likely to detract from the
individual’s optimal enjoyment of work and leisure activi
ties. Further research is needed to identify those individuals
who are at greatest risk of progressing from decreased
quality of life to clinically significant impairment in phys
ical, social, vocational, or mental status. We believe these
individuals are most likely to be encountered in clinical
settings and to have a body mass index �40 kg/m2 (11,69).
It is imperative that they receive appropriate medical
and behavioral care, independent of their desire or ability to
lose weight.
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